Payment of Interest in Cash or Kind. The Company shall pay interest to the Holder on the aggregate unconverted and then outstanding principal amount of this Debenture at the rate of 10% per annum, payable on the Maturity Date in cash or, at the Purchaser’s option, in duly authorized, validly issued, fully paid and non-assessable Ordinary Shares Conversion Rate.
Appears in 4 contracts
Samples: G Medical Innovations Holdings Ltd., G Medical Innovations Holdings Ltd., G Medical Innovations Holdings Ltd.
Payment of Interest in Cash or Kind. The Company shall pay interest to the Holder on the aggregate unconverted and then outstanding principal amount of this Debenture Note at the rate of 10% per annum, payable quarterly (as to that principal amount then being converted) and on the Maturity Date in cash or, at the PurchaserCompany’s option, in duly authorized, validly issued, fully paid and non-assessable Ordinary Shares Conversion Rateshares of Common Stock or a combination thereof at the lesser of $0.15 or the then applicable conversion price.
Appears in 3 contracts
Samples: Xenetic Biosciences, Inc., Xenetic Biosciences, Inc., Xenetic Biosciences, Inc.
Payment of Interest in Cash or Kind. The Company shall pay interest to the Holder on the aggregate unconverted and then outstanding principal amount of this Debenture at the rate of 108% per annum. All interest payments hereunder will be payable in cash, payable on or subject to the Maturity Date Equity Conditions, in cash or, at or common stock in the PurchaserCompany’s option, in duly authorized, validly issued, fully paid and non-assessable Ordinary Shares Conversion Ratediscretion.
Appears in 2 contracts
Samples: Notis Global, Inc., Medbox, Inc.
Payment of Interest in Cash or Kind. The Company shall pay interest to the Holder on the aggregate unconverted and then outstanding principal amount of this Debenture at the rate of 10% per annum, payable on the Maturity Date Date, and thereafter subject to increase pursuant to clause (d) below, in cash or, at the PurchaserHolder’s option, in duly authorized, validly issued, fully paid and non-assessable Ordinary Shares at the Conversion RatePrice.
Appears in 2 contracts
Samples: G Medical Innovations Holdings Ltd., G Medical Innovations Holdings Ltd.
Payment of Interest in Cash or Kind. The Company shall pay interest to the Holder on the aggregate unconverted and then outstanding principal amount of this Debenture at the rate of 10% per annum, payable on the Maturity Date semi-annually, in cash or, at the PurchaserHolder’s option, in duly authorized, validly issued, fully paid and non-assessable Ordinary Shares shares of Common Stock at the Conversion RatePrice.
Appears in 2 contracts
Samples: Blue Calypso, Inc., Blue Calypso, Inc.
Payment of Interest in Cash or Kind. The Company shall pay interest to the Holder on the aggregate unconverted and then outstanding principal amount of this Debenture Note at the rate of 1012% per annum, payable on each Conversion Date and on the Maturity Date in cash or, at the PurchaserCompany’s option, in duly authorized, validly issued, fully paid and non-assessable Ordinary Shares Conversion Rateshares of Common Stock or a combination thereof.
Appears in 2 contracts
Samples: Electronic Cigarettes International Group, Ltd., Electronic Cigarettes International Group, Ltd.
Payment of Interest in Cash or Kind. The Company shall pay interest to the Holder on the aggregate unconverted and then outstanding principal amount of this Debenture at the rate of 10% per annum, payable on the earlier of the Conversion Date or the Maturity Date with respect to the principal amount converted or maturing on such date, as applicable (each such date, an “Interest Payment Date”), in cash oror shares of Common Stock at the Interest Conversion Rate, or a combination thereof, at the PurchaserCompany’s option, in duly authorized, validly issued, fully paid and non-assessable Ordinary Shares Conversion Rate.
Appears in 1 contract
Samples: Almadoro Minerals Corp.
Payment of Interest in Cash or Kind. The Company shall pay interest to the Holder on the aggregate unconverted and then outstanding principal amount of this Debenture Note at the rate of 10% per annum, payable quarterly (as to that principal amount then being converted) and on the Maturity Date in cash or, at the PurchaserCompany’s option, in duly authorized, validly issued, fully paid and non-assessable Ordinary Shares Conversion Rateshares of Common Stock or a combination thereof at the lesser of $4.95 or the then applicable conversion price.
Appears in 1 contract
Samples: Xenetic Biosciences, Inc.
Payment of Interest in Cash or Kind. The Company shall pay interest to the Holder on the aggregate unconverted and then outstanding principal amount of this Debenture at the rate of 105% per annum. All interest payments hereunder will be payable in cash, payable on or subject to the Maturity Date Equity Conditions, in cash or, at or common stock in the PurchaserCompany’s option, in duly authorized, validly issued, fully paid and non-assessable Ordinary Shares Conversion Ratediscretion.
Appears in 1 contract
Samples: Medbox, Inc.
Payment of Interest in Cash or Kind. The Company shall pay interest to the Holder on the aggregate unconverted and then outstanding principal amount of this Debenture at the rate of 10% per annum, payable on the Maturity Date Date, and thereafter subject to clause (d) below, in cash or, at the Purchaser’s option, in duly authorized, validly issued, fully paid and non-assessable Ordinary Shares at the Conversion RatePrice.
Appears in 1 contract
Samples: G Medical Innovations Holdings Ltd.